Michael Arenberg - Mar 23, 2022 Form 4 Insider Report for Imago BioSciences, Inc. (IMGO)

Role
Company's Chief Operating and Business Officer
Signature
/s/ Hugh Rienhoff, as Attorney-in-fact for Michael Arenberg
Stock symbol
IMGO
Transactions as of
Mar 23, 2022
Transactions value $
$0
Form type
4
Date filed
3/25/2022, 04:13 PM
Previous filing
Jan 10, 2022
Next filing
Nov 14, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Stock Option (Right to Buy) Award $0 +371K $0.00 371K Mar 23, 2022 Common Stock 371K $18.44 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the first anniversary measured from March 23, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Remarks:

Company's Chief Operating and Business Officer